KASINGER JAMES R. — SEC Form 4 filings
SEC reporting owner CIK 1708172. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-21 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 11 filings — 38,262 shares, $2,073,276 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: sale of 9,595 shares @ $53.85 ($516,691) in CRISPR Therapeutics AG, filed 2025-02-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | General Counsel and Secretary | 16 | — | 14 legs · 38,262 sh · $2,073,276 | 38 |
Form 4 filings — KASINGER JAMES R.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2026-03-24 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 6,250 · Sale (S): 3,182 @ $46.78 · Grant/award (A): 38,499 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) | EDGAR |
| 2026-03-17 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 6,875 · Sale (S): 3,450 @ $48.26 · Option exercise (M): 6,875 (derivative) | EDGAR |
| 2026-03-12 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 5,500 · Sale (S): 2,800 @ $52.80 · Option exercise (M): 5,500 (derivative) | EDGAR |
| 2026-02-20 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 3,825 · Sale (S): 2,112 @ $52.58 · Option exercise (M): 3,825 (derivative) | EDGAR |
| 2025-10-15 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 2,114 · Sale (S): 1,076 @ $66.60 · Option exercise (M): 2,114 (derivative) | EDGAR |
| 2025-10-03 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2025-03-24 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 6,250 · Sale (S): 3,185 @ $41.23 · Option exercise (M): 6,250 (derivative) | EDGAR |
| 2025-03-18 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 36,666 (derivative) @ $0 · Grant/award (A): 27,500 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 5,500 · Sale (S): 2,850 @ $42.42 · Option exercise (M): 2,250 · Sale (S): 1,116 @ $43.32 · Option exercise (M): 5,500 (derivative) · Option exercise (M): 2,250 (derivative) | EDGAR |
| 2025-02-19 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 20,000 · Sale (S): 9,595 @ $53.85 · Option exercise (M): 3,825 · Sale (S): 1,947 @ $52.80 · Option exercise (M): 20,000 (derivative) · Option exercise (M): 3,825 (derivative) | EDGAR |
| 2024-10-18 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 18,333 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 2,113 · Sale (S): 1,089 @ $46.28 · Option exercise (M): 2,113 (derivative) | EDGAR |
| 2024-03-22 | 4 | CRISPR Therapeutics AG (CRSP) | Grant/award (A): 33,333 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 5,500 · Sale (S): 2,801 @ $78.26 · Option exercise (M): 2,250 · Sale (S): 1,146 @ $74.44 · Option exercise (M): 5,500 (derivative) · Option exercise (M): 2,250 (derivative) | EDGAR |
| 2024-02-21 | 4 | CRISPR Therapeutics AG (CRSP) | Option exercise (M): 3,825 · Sale (S): 1,913 @ $79.67 · Option exercise (M): 3,825 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1708172 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →